Your session is about to expire
← Back to Search
Treatment with Lavender for Intracranial Disease
Phase 1
Waitlist Available
Led By Richard A Rovin, MD
Research Sponsored by Aurora Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Any adult patient aged 18 and older undergoing awake cranial neurosurgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 hours
Awards & highlights
Study Summary
Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of consented patients
Protocol completion
Secondary outcome measures
Analgesic and anxiolytic dosage
Patient Opinion of Pain Management (POPM) survey
Validation of Visual Analogue Scale for Anxiety (VAS-A)
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Treatment with LavenderExperimental Treatment1 Intervention
Lavender (Lavandula angustifolia) aromatherapy will be administered at regular intervals using a nasal inhaler.
Find a Location
Who is running the clinical trial?
Aurora Health CareLead Sponsor
42 Previous Clinical Trials
15,992 Total Patients Enrolled
Richard A Rovin, MDPrincipal InvestigatorAurora Health Care
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger